Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes

BACKGROUND: Understanding mid-term kinetics of immunity to SARS-CoV-2 is the cornerstone for public health control of the pandemic and vaccine development. However, current evidence is rather based on limited measurements, losing sight of the temporal pattern of these changes. METHODS: We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradenas, Edwards, Trinité, Benjamin, Urrea, Víctor, Marfil, Silvia, Ávila-Nieto, Carlos, Rodríguez de la Concepción, María Luisa, Tarrés-Freixas, Ferran, Pérez-Yanes, Silvia, Rovirosa, Carla, Ainsua-Enrich, Erola, Rodon, Jordi, Vergara-Alert, Júlia, Segalés, Joaquim, Guallar, Victor, Valencia, Alfonso, Izquierdo-Useros, Nuria, Paredes, Roger, Mateu, Lourdes, Chamorro, Anna, Massanella, Marta, Carrillo, Jorge, Clotet, Bonaventura, Blanco, Julià
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Clinical and Translational Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847406/
https://www.ncbi.nlm.nih.gov/pubmed/33554155
http://dx.doi.org/10.1016/j.medj.2021.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847406/
https://www.ncbi.nlm.nih.gov/pubmed/33554155
http://dx.doi.org/10.1016/j.medj.2021.01.005

Ejemplares similares